Sevki KONUR, İsmet KIZILKAYA, Ergin TURGUT, Güner KILIÇ, Mehmet Ali BİLGİLİ, Ramazan DERTLİ, Yusuf KAYAR

Features of Endoscopic Findings In Patients With Hypothyroidism Secondary To Hashimoto Thyroiditis

The most common cause of hypothyroidism is Hashimoto's disease, Hypothyroidism slows down all metabolic events. Therefore, it has a motility-reducing effect on the intestine. In our study, we aimed to examine the differences between hypothyroid patients and the healthy control group who underwent upper-gastrointestinal system endoscopy for dyspeptic complaints. Demographic data, drug, smoking and alcohol use, endoscopic, histological findings, data on TSH levels were documented. Data were analyzed statistically. Values with p>0.05 were considered significant. Endoscopic findings were compared between patients and control group. In addition, the effect of disease severity on mucosa was investigated. 61 hypothyroid patients, 50 non-hypothyroid patients with functional-dyspepsia, were included in the study. Alkaline reflux and gluten enteropathy were found with a significantly higher rate in hypothyroid patients. Alkaline reflux and gluten enteropathy were found with a significantly higher rate in the group with TSH level higher than 10 mIU/L. Atrophic gastritis was observed with a higher rate in the hypothyroid patient group and the group with high TSH, but it was not statistically significant. There was no difference between the groups in terms of other endos copic findings. Hashimoto's thyroiditis is a common autoimmune phenomenon. It is closely associated with other autoimmune events. Since hypothyroidism slows down the metabolic rate, the intestinal passage time is prolonged. As a result, alkaline reflux occurs in patients. However, the results we found need to be supported by prospective studies conducted with larger patient groups.

PDF

___

1. Zhang QY, Liu W, et al. Response Letter to the Editor: "Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroid ism". J Clin Endocrinol Metab. 2020 Oct 1;105(10):457.
2. Valdes-Socin H, Gonzalez-Aguilera B, Geenen V. Letter to the Editor: "Genetic Study in a Large Cohort Supported Different Pathogenesis of Graves' Disease and Hashimoto's Hypothyroid ism". J Clin Endocrinol Metab. 2020 Oct 1;105(10):456.
3. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097–1142.
4. Brent GA. Graves' Disease. N Eng J Med 2008;358:2594-2605.
5. Dertli R, Kayar Y, Surmeli N, et al. The Relationship Between The Presence of Gastrointestinal Symptoms and Anemia, Thyroid Functions and Bone Mineral Density In Celiac Patients. Eastern Journal of Medicine 24;3: 355-360.
6. Diamanti A, Ferretti F, Guglielmi R, et al. Thyroid autoimmunity in children with coeliac disease: a prospective survey. Arch Dis Child 2011;96:1038–1041.
7. Centanni M, Marignani M, Gargano L, et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intrn Med 1999;159:1726-1730.
8. Yaylali O, Kirac S, Yilmaz M, et al. Does hypothyroidism affect gastrointestinal motility? Gastroenterol Res Pract 2009;2009:529802.
9. Lauritano EC, Bilotta AL, Gabrielli M, et al. Association between hypothyroidism and small intestinal bacterial overgrowth. J Clin Endocrinol Metab 2007;92:4180–4184.
10. Silveira MG, Mendes FD, Diehl NN, Enders FT, Lindor KD. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int 2009;29:1094–1100.
11. Hassan MM, Kaseb A, Li D, et al. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 2009;49:1563–1570.
12. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102(1):330-354.
13. Cesarini M, Angelucci E, Rivera M, et al. Thyroid disorders and inflammatory bowel diseases: retrospective evaluation of 909 patients from an Italian Referral Center. Inflamm Bowel Dis 2010;16:186–187.
14. Daher R, Yazbeck T, Jaoude JB, Abboud B. Consequences of dysthyroidism on the digestive tract and viscera. World J Gastroenterol 2009;15:2834–2838.
15. Maser C, Toset A, Roman S. Gastrointestinal manifestations of endocrine disease. World J Gastroenterol 2006;12:3174–3179.
16. 16. Kayar Y, Dertli R, Konur S, et al. The development of extraintestinal manifestation and related risk factors in Crohn’s patients. Irish Journal of Medical Science 2020;3:1-8.
17. 17. Kayar Y, Dertli R, Surmeli N, Bilgili MA. Extraintestinal Manifestations Associated with Celiac Disease. Eastern Journal of Medicine 24;4:478-483.
18. 18- Barbesino G, Tomer Y. Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab 2013;98:2247–2255.
19. 19- Kyriacou A, McLauglin J, Syed AA. Thyroid disorders and gastrointestinal and liver dysfunction: A state of the art review. Eur J Intern Med. 2015;26(8):563-571.
20. 20- Carvalho GA, Fighera TM. Effect of gastrointestinal disorders in autoimmune thyroid diseases. Transl Gastrointest Cancer 2015:4(1):76-82.
21. 21- Kayar Y, Dertli R. Association of autoimmune diseases with celiac disease and its risk factors. Pak J Med Sci. 2019;35(6):1548-1553.
22. 22- Cellini M, Santaguida MG, Virili C, et al. Hashimoto’s Thyroiditis and Autoimmune Gastritis. Frontiers in Endocrinology, 2017;8:92.
23. 23- Alexandraki KI, Nikolaou A, Thomas D, et al. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1? Clinical Endocrinology 2013; 80(5):685–690.